Breaking News
Subscribe Now 0
🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now. Pick Stocks with AI
Close

Amarin Corporation PLC (AMRN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amarin's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.586 +0.006    +1.72%
01/11 - Closed. Currency in USD
After Hours
0.600
+0.014
+2.389%
19:33:32 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 803,613
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.580 - 0.606
Amarin 0.586 +0.006 +1.72%

NASDAQ:AMRN Financials

 
A brief overview of the NASDAQ:AMRN financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Amarin over time.

Amarin Corporation plc reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported revenue was USD 42.3 million compared to USD 66.06 million a year ago. Net loss was USD 25.13 million compared to USD 19.31 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to USD 0.05 a year ago. For the nine months, revenue was USD 166.31 million compared to USD 232.2 million a year ago. Net loss was USD 33.57 million compared to USD 53.33 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.13 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.13 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AMRN Income Statement

Gross margin TTM 56.46%
Operating margin TTM -18.21%
Net Profit margin TTM -16.32%
Return on Investment TTM -6.44%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 42.3 67.49 56.52 74.71
Gross Profit 16.28 42.77 31.9 45.12
Operating Income -25.17 -0.524 -13.58 -4.61
Net Income -25.13 1.52 -9.95 -5.78

AMRN Balance Sheet

Quick Ratio MRQ 2.08
Current Ratio MRQ 3.23
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.55%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 750.62 799.86 790.01 831.68
Total Liabilities 219.24 247.98 244.08 279.59
Total Equity 531.38 551.88 545.94 552.1

AMRN Cash Flow Statement

Cash Flow/Share TTM -0.04
Revenue/Share TTM 0.59
Operating Cash Flow  -1.17%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -2.36 -2.75 -12.6 -0.645
Cash From Investing Activities -56.55 4.7 28.72 -71
Cash From Financing Activities -0.068 0.034 -1.43 0.083
Net Change in Cash -58.98 1.98 14.69 -71.56
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMRN Comments

Write your thoughts about Amarin Corporation PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alberto Casserà
Alberto Casserà May 05, 2022 9:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.25/30 soon…and 🚀🚀
Paul John
Paul John Feb 03, 2022 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There are some interesting articles and preprints on researchgate in regards to vascepa as a treatment for long covid
Ren Raku
Renraku Nov 22, 2021 10:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats happend?
Michal Bejr
Michal Bejr Mar 30, 2021 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
EU approval, nice
Mike Cornell
TheeAlmighty Mar 21, 2021 9:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Holding April 30 6.50 strike call options for EU approval!
Giovanni Gambino
Giovanni Gambino Mar 20, 2021 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
over 20 Dollar end of this year
Mike Cornell
TheeAlmighty Mar 08, 2021 12:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$8 this week
Marc Draaisma
Marc Draaisma Mar 05, 2021 6:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Helmut Hay
Helmut Hay Feb 24, 2021 3:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What Does champ mean
Michal Bejr
Michal Bejr Feb 01, 2021 9:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-positive-chmp-opinion-icosapent-ethyl
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email